Abstract:Objective:To investigate the effect of MMP28 on bladder cancer clinicopathologic characteristics and progression.Methods:Expression of MMP28 in 8 frozen bladder cancer tissues and paired normal bladder tissues were dectected by real-time polymerase.And expression of MMP28 in 173 paraffin-embedded stored specimens from patients with bladder cancer were dectected by immunohistochemical stain in this study.Statistical analysis of the relationship between the expression of MMP28 and clinicopathologic characteristics or progression was performed by x2 test,Kaplan-Meier method and cox regression.Results:Compared with paired normal baldder tissue,expression of MMP28 RNA was significantly increased in bladder cancer tissue.Immunochemistry data indicated expression of MMP28 protein was closely related to age,grade,and clinical stage(P=0.039,P=0.024,and P=0.003,respectively),rather than its gender,and tumor size,and tumor number(P=0.120,P=0.266,and P=0.462,respectively).Survival analysis suggest expression of MMP28 in bladder cancer had a significant relation to overall survival rate and progression-free survival rate(P=0.002,P=0.001).Univariate analysis indicated the prognosis of bladder cancer was associated to age(P =0.006,P =0.007),grade(P =0.008,P =0.006),tumor number (P=0.012,P=0.013),clinical stage(P=0.003,P=0.003),and MMP28(P =0.002,P =0.001).Moreover,Multivariate analysis suggested expression of MMP28 (P=0.037,P=0.045) was the only independent progonostic factor in bladder cancer besides clincal stage(P=0.022,P=0.043).Conclusion:The expression of MMP28 in bladdder cancer was significantly increased.The expression of MMP28 in bladdder cancer has a positive correlation with older age,high histological grade,late clinical stage and poor prognosis.As a independent progonostic factor in bladder cancer,MMP28 can be a potential target for the treatment.

Expression and Clinical Significance of a Disintegrin and Metalloproteinase-12 and Proliferating Cell Nuclear Antigen in Bladder Carcinoma

Expression and Clinical Significance of ADAM-12 and PCNA in Bladder Carcinoma

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Expression of proliferation cell nuclear antigen in bladder carcinoma and its clinical significance

Expression and Significance of PCNA Protein and MVD in Pancreatic Adenocarcinoma

Relationship between the expression of mutant P53 and PCNA and their clinical significances in transitional cell carcinoma of the bladder

The Correlation in Transcriptional Expression with Promoter Hypermethylation of AKAP12 Gene in Bladder Transitional Cell Carcinoma

Expressions and clinical significances of PTEN and P53 gene in non-muscle-invasive bladder cancer

Expression of E-Cadherin and Α-Catenin in Bladder Transitional Cell Carcinoma and Its Clinical Significance

The Expression of PCNA Protein and Its Relationship with Recurrence of Bladder Cancer

EXPRESSION AND PROGNOSTIC EVALUATION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER

Expression of PCNA in Human Bladder Transitional Cell Carcinoma and Its Clinical Significance

Expressions of P16 Protein and PCNA in Transitional Cell Carcinoma of the Urinary Bladder and Their Implications

The Expression and Significance of TEP1 and CDK4 Proteins in Bladder Carcinoma

Expression of MMP-2, MMP-9 and CD147 and Their Relationships in Bladder Transitional Cell Carcinoma

The Expression of VASP and PCNA in Colorectal Adenocarcinomas

Expression and relationship between PTEN and MMP-2 in bladder transitional cell carcinoma

Expression of E-cadherin and PCNA in pancreatic adenocarcinoma and their clinic significance

Relationship of VEGF,PCNA,Survivin and pathological grading,clinical stage of bladder cancer

MMP28 Expression in Blander Cancer and Its Clinical Significance

Expressions and Significance of HER-2 and MMP-2 in Bladder Transitional Cell Carcinoma